Not exact matches
In listening to our terminally ill patients, we were always impressed that even the
most accepting, the
most realistic patients left the possibility open for some cure, for the
discovery of a new
drug or the «last minute success in a
research project.»
The
discovery involved ORNL's Spallation Neutron Source, which provides the
most intense pulsed neutron beams in the world for scientific
research and industrial development, and ORNL's Titan supercomputer, the nation's
most powerful for open science — a one - two punch for illuminating the physical properties of potential
drugs that inform new design principles for safer, improved delivery platforms.
One of the
most exciting recent advances in clinical cancer
research was the
discovery that this subgroup of patients respond — sometimes dramatically — to a new class of
drugs targeting the MAPK pathway through which BRAF signals.
Dr Iain Foulkes, Cancer
Research Technology's CEO, said: «This bold and exciting collaboration between one of industry's leading innovators, Celgene, and CRT is part of our theme - based
drug discovery approach and helps leverage our understanding of cancer biology and the needs of patients to drive the
most promising
discoveries into the clinic.
SBP is home to one of the
most comprehensive non-profit
drug discovery platforms, is dedicated to
research in childhood diseases, and pioneers advances in molecular stem cell
research.
Research yields promising
drug targets impacting underlying biology of the disease; Findings form the basis of deCODE's
most advanced
drug discovery program Reykjavik, ICELAND, July 24, 2002 — deCODE genetics (Nasdaq / Nasdaq Europe: DCGN) today announced the publication...
Despite ongoing efforts toward finding novel entities for the treatment of the
most challenging cancers, translation into patient benefit has been slow due to the fact that translational cancer
research from early
drug discovery to late stage
drug development and assessment in clinical trials is a long process.